register

ESG

Hepatitis Australia announces new CEO

Health Industry Hub | March 6, 2020 |

Hepatitis Australia has appointed Carrie Fowlie as its incoming Chief Executive Officer.

Following the retirement of Helen Tyrrell at the beginning of February, Hepatitis Australia undertook a rigorous recruitment process to identify the person to take over the operational leadership of the organisation and work closely with the Board.

Hepatitis Australia President, A/Prof. Grant Phelps said, “the Board is delighted that Carrie has accepted the position of CEO.  Carrie brings deep experience and knowledge of the sector and is well known to and highly regarded by many who have worked with Hepatitis Australia.”

“Carrie is very well positioned to assist the Board and staff of Hepatitis Australia to continue to drive towards improving the lives of people with hepatitis B and hepatitis C and our vison of an end to viral hepatitis in Australia”

Carrie heads to Hepatitis Australia with almost two decades of peak body experience.

Carrie has extensive representational experience at the national and international level. Her work with elected officials and their offices, in parliaments, at the United Nations and with government officials has resulted in policies that are consistent with the evidence and the priorities of the constituencies she has represented.

Carrie Fowlie said, “the leadership of Hepatitis Australia with its members, affected communities, the sector and allies over the past decade has been transformative.”

“What an extraordinary opportunity, working together to achieve a shared goal of eliminating viral hepatitis by 2030.”

“I look forward to contributing to the health and wellbeing and strengthening the voices of around 400,000 Australians living with hepatitis B or hepatitis C and those who represent them.”

Acting CEO, Kevin Marriott says, “the staff team at Hepatitis Australia is excited to welcome Carrie and we look forward to her leadership and guidance into the future.

Carrie Fowlie will formally commence with Hepatitis Australia in mid-April, 2020.

Register FREE to receive the latest industry news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.


News & Trends - Biotechnology

Aussie biotech secures agreement with UQ and USyd to advance cardiovascular diseases research

Aussie biotech secures agreement with UQ and USyd to advance cardiovascular diseases research

Health Industry Hub | July 26, 2024 |

Biotech News: Australian biotechnology company, Cartherics, developing immune cell therapies for the treatment of cancer, has entered into a Technology […]

More


News & Trends - MedTech & Diagnostics

NSW Health Secretary urges more focus on patient experience, drawing from her own heart valve disease journey

NSW Health Secretary urges more focus on patient experience, drawing from her own heart valve disease journey

Health Industry Hub | July 26, 2024 |

In a heart-warming event that united patients, their loved ones, representatives from patient organisations and employees, Edwards Lifesciences hosted its […]

More


Human Resources

'To be an inclusive society, we need an embedded national strategy to combat systemic racism', says Commissioner Sivaraman

‘To be an inclusive society, we need an embedded national strategy to combat systemic racism’, says Commissioner Sivaraman

Health Industry Hub | July 26, 2024 |

Race Discrimination Commissioner Giridharan Sivaraman has welcomed the release of the Multicultural Framework Review by the Federal Government, calling it […]

More


News & Trends - Pharmaceuticals

New shingles vaccine is linked with lower risk of dementia

Shingles vaccine lowers risk of dementia

Health Industry Hub | July 26, 2024 |

Pharma News: A recombinant shingles vaccine which was added to Australia’s National Immunisation Program (NIP) in November last year, is […]

More


This content is copyright protected. Please subscribe to gain access.